The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
The Oncology Institute (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the 25th Annual Needham Healthcare Conference on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the 25th Annual Needham Healthcare Conference on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A live webcast of the presentation will be accessible via the company's Investor Relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TOI
On Apr 9, the day this news came out, TOI closed 0.32% above the previous close.
Data tracked by StockTitan Argus for the Apr 9 session.
Key Figures
- Conference edition
- 25th Annual
- Needham Healthcare Conference
- Conference date
- April 15, 2026
- Needham Healthcare Conference presentation
- Presentation time
- 3:45 p.m. ET
- Fireside chat at Needham Healthcare Conference
Historical Context
-
Named a new Chief Legal Officer to oversee legal and compliance functions.
-
Reported strong 2025 revenue growth and issued 2026 financial guidance.
-
Announced timing and access details for Q4 and full-year 2025 earnings call.
-
Outlined participation in multiple healthcare investor conferences in March 2026.
-
Appointed an experienced healthcare executive to the Board of Directors.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.